MSc, PhD from the University of Delhi and CSIR Institute of Genomics and Integrative Biology, Delhi, NASA Fellow, Founder Director of the Centre for Infection, Immunity and Disease Mechanisms, Brunel University London, Welcome Trust International Fellow and Alexander Humboldt Fellow, University of Oxford Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Professor University Of UAE Veterinary Faculty.
Dr Uday Kishore, PhD, FHEA, FRSB is a teacher and a scientist with special interest in innate immunity. He earned his PhD from the University of Delhi and CSIR Institute of Genomics and Integrative Biology, Delhi, India. After spending a year at the Salk Institute for Biological Studies, La Jolla, California as a NASA Fellow, he moved to the University of Oxford for the most part of his post-doctoral training, first at the MRC Immunochemistry Unit, Department of Biochemistry and then at the Weatherall Institute of Molecular Medicine, John Radcliffe Hospital. His previous positions include NASA fellow, Wellcome Trust International Fellow and Alexander Humboldt fellow. He is also the recipient of MRC Investigator Prize, European Commission Young Scientist Prize, and Mother Teresa Excellence Award. Dr Kishore has several adjunct and professorial positions internationally. He was the Founder Director of the Centre for Infection, Immunity and Disease Mechanisms, Brunel University London. Dr Kishore has authored over 200 peer-reviewed research papers, 40 book chapters, 6 patents, edited 10 books, and is currently writing a text book on host pathogen interaction. His research team is currently trying to understand how the innate immune components deal with self, non-self and altered self. Mostly revolving around complement proteins (specially C1q, factor H and properdin) and C-type lectins (SP-A, SP-D and DC-SIGN), (1) we examine their importance in host-pathogen interaction using HIV-1, Influenza A virus, SARS-CoV-2, Mycobacterium tuberculosis and Aspergillus fumigatus as model pathogens; (2) we are trying to ascertain their role as immune surveillance molecules in allergy (ABPA, allergic rhinitis and dust mite allergy); cancer (pancreatic, breast and ovarian cancers; leukaemia, glioblastoma, and mesothelioma); and human pregnancy; and (3) we are devising drug delivery strategies in allergy and cancer through nanoparticles. Further details about his professional activities can be found via https://scholar.google.com/citations?user=Tw1_PkcAAAAJ&hl=en&oi=ao; https://www.researchgate.net/; https://loop.frontiersin.org/people/24906/overview